Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Type I collagen inhibits differentiation and promotes a stem cell-like phenotype in human colorectal carcinoma cells
British Journal of Cancer, 07/02/09
Kirkland SC et al. - In a study to investigate the role of type I collagen in specifying the colorectal cancer (CRC) cell phenotype, these results indicate that type I collagen promotes expression of a stem cell-like phenotype in human CRC cells likely through α2β1 integrin.
Methods- The effect of type I collagen on morphology, localisation of cell–cell adhesion proteins, differentiation, and stem cell-like characteristics was examined in a panel of human CRC cell lines.
- Human CRC cells grown on type I collagen in serum-free medium show an epithelial–mesenchymal-like transition (EMT-like), assuming a more flattened less cohesive morphology.
- Type I collagen downregulates E-cadherin and β-catenin at cell–cell junctions.
- Type I collagen inhibits differentiation, increases clonogenicity, and promotes expression of stem cell markers CD133 and Bmi1.
- Type I collagen effects were partially abrogated by a function-blocking antibody to α2 integrin.
Related Articles
Colonic carcinoma with a pancreatic acinar cell differentiation. A case report
Virchows Archiv, 11/19/09
Relevance Score: 81%
Current therapeutic strategies for anal squamous cell carcinoma in Japan
International Journal of Clinical Oncology, 10/30/09
Relevance Score: 80%
Relationships of P53 and Bak with EPO and EPOR in Human Colorectal Cancer
Anticancer Research, 11/11/09
Relevance Score: 79%
Undifferentiated carcinoma of the ascending colon with prominent rhabdoid features: A case report
Basic and Applied Pathology, 11/09/09
Relevance Score: 79%
RAS Mutations Affect Tumor Necrosis Factor–Induced Apoptosis in Colon Carcinoma Cells via ERK-Modulatory Negative and Positive Feedback Circuits Along with Non-ERK Pathway Effects
Cancer Research, 10/27/09
Relevance Score: 79%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells
Oncogene, 11/25/09
A novel translational approach for human malignant pleural mesothelioma: heparanase-assisted dual virotherapy
Oncogene, 11/25/09
Embryoid body formation of human amniotic fluid stem cells depends on mTOR
Oncogene, 11/25/09
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell–fibronectin adhesion of colon cancer cells
Oncogene, 11/25/09
A blood-based biomarker panel for stratifying current risk for colorectal cancer
International Journal of Cancer, 11/25/09
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
Molecular Cancer, 11/24/09
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 11/24/09
Pancreatic endocrine tumors: Expression profiling evidences a role for AKT-mTOR pathway
Journal of Clinical Oncology, 11/24/09
Insulin-like growth factor binding protein-3 has dual effects on gastrointestinal stromal tumor cell viability and sensitivity to the anti-tumor effects of imatinib mesylate in vitro
Molecular Cancer, 11/23/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


